Long-term treatment results in breast cancer patients with skin edema and an incomplete response to neoadjuvant drug therapy

Close metadata

OBJECTIVE

To assess long-term treatment results in breast cancer patients with skin edema and an incomplete response to neoadjuvant drug therapy.

Subjects and methods. The study enrolled 182 breast cancer patients with skin edema and an incomplete response to neoadjuvant drug treatment. The patients were divided into 3 groups: 1) 91 patients who had undergone surgery followed by external beam radiation therapy (EBRT); 2) 41 who had received radiation therapy according to a radical program without subsequent surgery; 3) 50 patients who had induction radiation therapy followed by surgery.

RESULTS

The overall 10-year survival rates in Group 1 were better than those in Group 3 (47.8% vs 20.7%; p=0.017). There was also a tendency to increase the survival rate when comparing the indicators of Groups 1 and 2 (47.8% vs 38.2%; p=0.081). Analysis of relapse-free survival showed statistically significant differences over a 5-year follow-up period between Groups 1 and 2 (54.7% vs 40.7%; p=0.032). During a 10-year follow-up period, there was a trend towards an increase in indicators (50.2% vs 23.8%; p=0.06). The 5-year locoregional recurrence-free survival was also significantly better in Group 1 than in Group 3 (87.6% vs 74.7%). During a 10-year follow-up period, there is also a tendency to increase this survival rate at 10 years in Groups 1 and 3 (85% vs 74.7%; p=0.078), as well as at similar time in Group 1 and 2 (85% vs 72.3%; p=0.085). The distant metastasis-free survival rates was statistically significantly higher only at a 5-year follow-up period in Group 1 than in Group 3 (58.4% vs 41.0%; p=0.05).

CONCLUSION

The investigation has demonstrated that persistent skin edema should not be an obstacle to surgical intervention. An integrated approach (neoadjuvant drug therapy followed by surgery and EBRT) has shown the greatest effectiveness in the treatment of these patients.

Keywords:

breast cancer

skin edema measurement

long-term results

prognostic factors

Authors:

Amosova V.A.

Blokhin National Medical Cancer Research Center

Petrovsky A.V.

Blokhin National Medical Cancer Research Center;
Sechenov First Moscow State Medical University

Trofimova O.P.

N.N. Blokhin National Medical Research Center of Oncology

Frolova M.A.

N.N. Blokhin National Medical Research Center of Oncology

Karpova M.S.

Yaroslavl State Medical University

Ponedelnikova N.V.

N.N. Blokhin National Medical Research Center of Oncology

Pritula S.I.

N.N. Blokhin National Medical Research Center of Oncology

Received:

06.05.2022

Accepted:

19.05.2022

List of references:

Kaprin AD, Starinskii VV, Shakhzadova AO, eds. Sostoyanie onkologicheskoi pomoshchi naseleniyu Rossii v 2020. Moscow: MNIOI im. P.A. Gertsena — filial FGBU «NMITs radiologii» Ministerstva zdravookhraneniya Rossiiskoi Federatsii; 2021. (In Russ.).
Padhani AR, Ollivier L. The RECIST (Response Evaluation Criteria in Solid Tumors) criteria: implications for diagnostic radiologists. Br J Radiol. 2001;74(887):983-986. https://doi.org/10.1259/bjr.74.887.740983
Pope TLJr, Read ME, Medsker T, Buschi AJ, Brenbridge AN. Breast skin thickness: normal range and causes of thickening shown on film-screen mammography. J Can Assoc Radiol. 1984;35(4):365-368.
Burdina LM, Vaisblat AV, Vesnin SG, Konkin MA, Lashchenkov AV, Naumkina NG. Tikhomirova NN. Primenenie radiotermometrii dlya diagnostiki raka molochnoi zhelezy. Mammologiya. 1998;(2):3-12. (In Russ.).
Carr KL. Microwave radiometry: its importance to the detection of cancer. IEEE Transactions on Microwave Theory and Techniques. 1989;37(12):1865-1869. https://doi.org/10.1109/22.44095
Moiseenko VM, Semiglazov VF. Kineticheskie osobennosti rosta raka molochnoi zhelezy i ikh znachenie dlya rannego vyyavleniya opukholi. Mammologiya. 1997;(3):3-12. (In Russ.).
Huang SY, Boone JM, Yang K, Kwan ALC, Packard NJ. The effect of skin thickness determined using breast CT on mammographic dosimetry. Med Phys. 2008;35(4):1199-1206. https://doi.org/10.1118/1.2841938
Ermakov AV, Saribekyan EK, Stepanov SO, Rubtsova NA, Kolesnikova EV. The using of the instrumental methods of skin thickness measurement for the diagnosis of inflammatory breast cancer. Malignant Tumours=Zlokachestvennye opukholi. 2015;(4):24-27. (In Russ.). https://doi.org/10.18027/2224—5057—2015—4-24—27
Londero V, Bazzocchi M, Del Frate C, Puglisi F, Di Loreto C, Francescutti G, Zuiani C. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol. 2004;14(8):1371-1379. https://doi.org/10.1007/s00330-004-2246-z
Hamisa M, Dabess N, Yosef R, Zakeria F, Hammed Q. Role of breast ultrasound, mammography, magnetic resonance imaging and diffusion weighted imaging in predicting pathologic response of breast cancer after neoadjuvant chemotherapy. Egypt J Radiol Nucl Med. 2015;46(1):245-257. https://doi.org/10.1016/j.ejrnm.2014.11.011
Shoma A, Moutamed A, Ameen M., Abdelwahab A. Ultrasound for accurate measurement of invasive breast cancer tumor size. Breast J. 2006;12(3):252-256. https://doi.org/10.1111/j.1075-122X.2006.00249.x
Wright FC, Zubovits J, Gardner S, Fitzgerald B, Clemons M, Quan ML, Causer P. Optimal assessment of residual disease after neo-adjuvant therapy for locally advanced and inflammatory breast cancer-clinical examination, mammography, or magnetic resonance imaging? J Surg Oncol. 2010;101(7):604-610. https://doi.org/10.1002/jso.21559
Chen M, Zhan WW, Han BS, Fei XC, Jin XL, Chai WM, Wang DB, Shen KW, Wang WP. Accuracy of physical examination, ultrasonography, and magnetic resonance imaging in predicting response to neo-adjuvant chemotherapy for breast cancer. Chin Med J (Eng). 2012;125(11):1862-1866.
Mateo AM, Mazor AM, DeMora L, Sigurdson ER, Handorf EA, Daly JM, Aggon AA, Obeid E, Hayes SB, Bleicher RJ. Patterns of care and efficacy of chemotherapy and radiotherapy in skin-involved breast cancers of all sizes. Clin Breast Cancer. 2019;19(4):292-303. https://doi.org/10.1016/j.clbc.2019.02.003
Silverman D, Ruth K, Sigurdson ER, Egleston BL, Goldstein LJ, Wong YN, Boraas M, Bleicher RJ. Skin involvement and breast cancer: are T4b lesions of all sizes created equal? J Am Coll Surg. 2014;219(3):534-544. https://doi.org/10.1016/j.jamcollsurg.2014.04.003
Klein J, Tran W, Watkins E, Vesprini D, Wright FC, Look Hong NJ, Ghandi S, Kiss A, Czarnota GJ. Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: a retrospective cohort analysis. BMC Cancer. 2019;19(1):306. https://doi.org/10.1186/s12885-019-5499-2
Damast S, Ho AY, Montgomery L, Fornier MN, Ishill N, Elkin E, Beal K, McCormick B. Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane era. Int J Radiat Oncol Biol Phys. 2010;77(4):1105-1112. https://doi.org/10.1016/j.ijrobp.2009.06.042
Hortobagyi GN, Ames FC, Buzdar AU, Kau SW, McNeese MD, Paulus D, Hug V, Holmes FA, Romsdahl MM, Fraschini G, et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer. 1988;62(12):2507-2516. https://doi.org/10.1002/1097-0142(19881215)62:12<2507::aid-cncr2820621210>3.0.co;2-d "> 3.0.co;2-d" target="_blank">https://doi.org/10.1002/1097-0142(19881215)62:12<2507::aid-cncr2820621210>3.0.co;2-d
Alvarado-Miranda A, Arrieta O, Gamboa-Vignolle C, Saavedra-Perez D, Morales-Barrera R, Bargallo-Rocha E, Zinser-Sierra J, Perez-Sanchez V, Ramirez-Ugalde T, Lara-Medina F. Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer. Radiat Oncol. 2009;4:24. https://doi.org/10.1186/1748-717X-4-24
Shanta V, Swaminathan R, Rama R, Radhika R. Retrospective analysis of locally advanced noninflammatory breast cancer from Chennai, South India, 1990-1999. Int J Radiat Oncol Biol Phys. 2008;70(1):51-58. https://doi.org/10.1016/j.ijrobp.2007.05.050
Corso G, Kahler-Ribeiro-Fontana S, Pagan E, Bagnardi V, Magnoni F, Munzone E, Bottiglieri L, Veronesi P, Galimberti V. Ten-year outcome results of cT4 breast cancer after neoadjuvant treatment. J Surg Oncol. 2021;124(8):1242-1250. https://doi.org/10.1002/jso.26662
Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, et al. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol. 2011;22(3):515-523. https://doi.org/10.1093/annonc/mdq345
Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, et al. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol. 2004;22(23):4691-4699. https://doi.org/10.1200/JCO.2004.11.129
McGuire, Gonzalez-Angulo AM, Huang EH, Tucker SL, Kau SW, Yu TK, Strom EA, Oh JL, Woodward WA, Tereffe W, et al. Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys. 2007;68(4):1004-1009. https://doi.org/10.1016/j.ijrobp.2007.01.023
van Uden DJP, van Maaren MC, Bult P, Strobbe LJA, van der Hoeven JJM, Blanken-Peeters CFJM, Siesling S, de Wilt JHW. Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer. Breast Cancer Res Treat. 2019;176(1):217-226. https://doi.org/10.1007/s10549-019-05219-7

Close metadata